Lower lows lower highs. Not good if you are long.
Baird analyst Brian Skorney reiterated an Outperform rating and $258 price target on Intercept Pharmaceuticals (NASDAQ: ICPT) saying an FDA authored hepatology articles provides a window into Phase 3 design.
"We're further encouraged on Intercept after the workshop manuscript from the joint meeting with the AASLD and FDA regarding endpoints in NASH trials was published in Hepatology," Skorney said. "We believe that the FDA is essentially acknowledging a path for approval in the article based on a surrogate that aligns well with the endpoint Intercept plans to target in a Phase 3 study."
For an analyst ratings summary and ratings history on Intercept Pharmaceuticals click here. For more ratings news on Intercept Pharmaceuticals click here.
You moron I shorted Line at $26 (3000 shares) cover in the pre market at $9.25 & $9.35 Was able to pick up 2000 shares of worthless LINE at $9 unloaded my 2000 shares at $11.35. Learn to trade fool! Traders make money investors get screw like you!
Jan 2 (Reuters) - Linn Energy LLC cut its 2015 capital budget by 53 percent to $730 million, joining other oil and gas producers in reducing expenditure in response to falling oil prices.
Linn also said it had reduced its distribution per unit and the dividend per share for subsidiary LinnCo to $1.25 each from $2.90 on an annualized basis.
Linn said it expected to fund its total 2015 oil and natural gas capital program, along with the distribution, from internally generated cash flow
Transactions in the Shares effected During the Last 60 Days
The following table sets forth all transactions in the Shares effected during the past sixty days by the Reporting Person. All such transactions were effected in the open market through brokers and the price per share is net of commissions.
Trade Date Shared Purchased (Sold) Price Per Share ($)
12/30/2014 (11,000) 4.05
12/30/2014 (10,000) 4.09
12/30/2014 (6,458,078) 4.13
12/30/2014 (5,564.682) 4.29
12/30/2014 (198,000) 4.30
With $10 Billion in debt, very small amount of cash on hand, & with cash flow barley able to meet debt loads, its a miracle it's still trading above $7
Speaking of Alpo, is that what you been eating for dinner for the last 3 months? Dam you are one stupid bag holder. Yes am winning this game because I have 20 plus years in trading this market, Un like you who hast to wait years to make a profit, I make a killing everyday. Enjoy your Alpo dinner tonight! LOl...
*** The Street sees Q1 revs of $228 million and FY15 at $817.2 million.
Entering 2015, the company has approximately 35% to 40% of its lodge rooms contracted in Canada, down from over 75% contracted for 2014 at the beginning of 2014. The company expects Canadian occupancy of 44% to 47% with an average daily rate of approximately C$139 to C$145 for 2015. In Australia, the company has approximately 35% to 40% of its village rooms contracted, down from over 55% contracted for 2014 at the beginning of 2014. Civeo expects Australian occupancy of 55% to 57% with an average daily rate of A$88 to A$95 for 2015.
In reaction to softer markets, the company is pursuing additional revenue opportunities, adjusting its cost structure, limiting capital expenditures and suspending its quarterly dividend.
Management is actively seeking short term accommodations agreements to augment contracted room revenue and maintain market share and providing certain services to third parties for a fee. Partially offsetting the expected reduction in lodge revenues is Civeo's recently completed McClelland Lake Lodge. In 2015, the company expects to begin realizing the full-year benefits of this 1,997 room facility, which has the majority of its rooms under contract through the first quarter of 2017.
In addition, the company has reduced headcount in its Canadian and U.S. operations by 30% and 45%, respectively, from levels at the beginning of 2014. These efforts have included closing locations which were unprofitable at the expected low levels of occupancy, including the temporary closure of the Athabasca Lodge and the permanent closure of the Lakeside Lodge as well as the continued assessment of two U.S. locations. In terms of its manufacturing operations, the company closed its Australian manufacturing location due to projected limited demand for additional rooms over the next several years and is assessing the manufacturing capacity required to support the North American market. 2015 operating costs are expected to decrease by more than 35% in Canada and by more than 15% in Australia from 2014 levels. Management also expects 2015 SG&A expenses in Canada to be approximately 20% lower than 2014 and more than 10% lower in Australia year-over-year. Management will continue to focus on operating costs as clarity on market conditions improves.
The company expects 2015 capital expenditures to be in the range of $75 million to $85 million, a significant reduction compared to estimated 2014 capital expenditures of approximately $260 million to $280 million. The 2015 capital expenditures guidance excludes up to approximately $50 million of capital for unannounced and uncommitted projects, the spending for which will be contingent on securing customer contracts.
In addition, as a result of the company's current outlook and guidance described above, the company could be required to record impairment charges related to the carrying value of its assets and/or goodwill.
Civeo (NYSE: CVEO) announced the company's initial 2015 guidance, which reflects decisions by major oil companies in North America to significantly reduce 2015 capital spending, particularly in Canada, continuing weakness in global commodity markets and the resulting impact on the company's business in Canada, Australia and the United States.
The acceleration in November of the decline in global crude oil prices and forecasts for a potentially protracted period of lower prices have resulted in major oil companies reducing their 2015 capital budgets from 2014 levels. This has had the effect of reducing the near-term allocation of capital to development or expansion projects in the oil sands, which is a major driver of demand for the company's services in Canada. It has also increased the difficulty of reliably estimating 2015 occupancy levels for the company's facilities. Likewise in Australia, persistently low metallurgical coal prices continue to negatively impact demand for accommodations in Civeo's primary markets. In addition to these operational factors, the company expects to be negatively impacted by the continuing weakness in the Canadian and Australian dollars, which are down 2% and 6%, respectively, over the past two months against the US dollar and down 8% and 9%, respectively, year-to-date in 2014.
Based on current information and expectations for demand, the company anticipates first quarter 2015 revenues will be in the range of $160 million to $175 million with EBITDA in the range of $45 million to $55 million. Management expects typical seasonality in 2015 in which second quarter earnings are sequentially lower with Canadian spring break up. Earnings in the second half of 2015 are expected to be sequentially weaker as certain contracts expire or are replaced with contracts
Get Alerts CVEO Hot Sheet
What is poor simple minded blackstone44 going to do now that he has lost all
$1.2 million imaginary money on CEVO? I guess it's time for him to move back into his parents basement & prays that Mickey Dee's hires him back a latrine manger. LOl... Love it when lying morons get caught with their foot in their mouths. Keep buying those dips boys!
If you think anyone believes you have $1.2 million to invest with, I have some under water property I can sell you! Cheap! Really Cheap!!! LOl... Where do these morons come from????